Trial of relaxation in reducing coronary risk: four year follow up

Insights

Mind-body interventions significantly reduced blood pressure in individuals with cardiovascular risk factors. These benefits were sustained at four years, leading to a lower incidence of ischemic heart disease.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Psychosomatic Medicine

Background:

  • Cardiovascular disease is a leading cause of mortality.
  • Lifestyle factors such as diet, smoking, and stress significantly contribute to cardiovascular risk.
  • Effective interventions are needed to manage modifiable risk factors.

Purpose of the Study:

  • To evaluate the long-term effectiveness of a behavioral modification program incorporating mind-body techniques on cardiovascular risk factors.
  • To assess the impact of the intervention on the incidence of ischemic heart disease.

Main Methods:

  • 192 adults (35-64 years) with at least two cardiovascular risk factors were randomized into a behavioral modification group or a control group.
  • The intervention group received health education plus weekly group sessions (8 weeks) including breathing exercises, relaxation, and stress management.
  • Both groups received health education leaflets.

Main Results:

  • The intervention group showed significantly greater reductions in systolic and diastolic blood pressure, sustained for four years.
  • While cholesterol and smoking rates improved short-term, these differences were not maintained at four years.
  • The control group had a higher incidence of angina, hypertension treatment, and ischemic heart disease events.

Conclusions:

  • Mind-body interventions, combined with lifestyle advice, are effective in reducing blood pressure long-term in at-risk individuals.
  • The intervention demonstrated a significant reduction in the incidence of ischemic heart disease.
  • These findings suggest substantial financial and healthcare benefits if implemented on a larger scale.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...